Uro-neurology: Phase I trials

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Mirabegron

Phase I

Multiple worldwide locations

Recruiting

Click here for further information